Cargando…
The Maudsley prescribing guidelines in psychiatry /
The fully updated 12th edition of an essential reference for anyone responsible for prescribing drugs for patients with mental health disorders. A well-respected and widely-used source of information on which drugs to prescribe, which side effects to look out for, how best to augment or switch drugs...
| Clasificación: | Libro Electrónico |
|---|---|
| Autores principales: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Chichester, West Sussex ; Hoboken, NJ :
John Wiley & Sons Inc.,
2015.
|
| Edición: | 12th edition. |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Title page; Table of Contents; Preface; Acknowledgements; Notes on using The Maudsley Prescribing Guidelines; Notes on inclusion of drugs; List of abbreviations; Chapter 1: Plasma level monitoring of psychotropic drugs; Interpreting sample results; References; Acting on clozapine plasma concentration results; References; Interpreting post-mortem blood concentrations; References; Chapter 2: Schizophrenia; ANTIPSYCHOTIC DRUGS; General introduction; References; General principles of prescribing; References; Minimum effective doses; References; Further reading.
- Quick reference for licensed maximum dosesEquivalent doses; References; High-dose antipsychotics: prescribing and monitoring; References; Antipsychotic prophylaxis; References; Combined antipsychotics; References; Negative symptoms; References; Monitoring; References; Relative adverse effects
- a rough guide; Treatment algorithms for schizophrenia; References; First-generation antipsychotics
- place in therapy; References; Omega-3 fatty acid (fish oils) in schizophrenia; References; New and developing drugs to treat schizophrenia; References.
- NICE guidelines for the treatment of schizophrenia1References; Antipsychotic response
- to increase the dose, to switch, to add or just wait
- what is the right move?; References; Antipsychotic long-acting injections; References; Further reading; Depot antipsychotics
- pharmacokinetics; References; Management of patients on long-term depots; References; Aripiprazole LAI; References; Olanzapine LAI; References; Paliperidone palmitate LAI; References; Risperidone LAI; References; ANTIPSYCHOTICS
- ADVERSE EFFECTS; Extrapyramidal side-effects; References; Further reading; Akathisia; References.
- Further readingWeight gain; References; Treatment of drug-induced weight gain; References; Tardive dyskinesia; References; Further reading; Neuroleptic malignant syndrome; References; Catatonia; References; QT prolongation; References; Further reading; Dyslipidaemia; References; Diabetes and impaired glucose tolerance; References; Hypertension; References; Hyponatraemia; References; Hyperprolactinaemia; References; Sexual dysfunction; References; Pneumonia; References; Switching antipsychotics; References; REFRACTORY SCHIZOPHRENIA AND CLOZAPINE; Clozapine
- dosing regimen; References.
- Optimising clozapine treatmentReferences; Further reading; Alternatives to clozapine; References; Re-starting clozapine after a break in treatment; Reference; Initiation of clozapine for community-based patients; Further reading; CLOZAPINE
- ADVERSE EFFECTS; Common adverse effects; References; Further reading; Clozapine: uncommon or unusual adverse effects; References; Clozapine: serious haematological and cardiovascular adverse effects; References; Further reading; Clozapine-induced hypersalivation; References; Further reading; Clozapine-induced gastrointestinal hypomotility (CIGH).